SEARCH

SEARCH BY CITATION

The International Society on Thrombosis and Haemostasis is an inclusive network of scientists dedicated to research, education and improvement of the lives of those who suffer with diseases and disorders of thrombosis, hemostasis and their underlying vascular biology. You are welcome to join ISTH by application and payment of annual membership dues.

Membership is individual and is not transferable. Categories of membership are:

Regular $160/year

Associate $35/year

Applications are accepted throughout the year and are not pro-rated.

For online enrollment, please visit http://isth.org. You may also email or telephone the Membership Secretary, Sharon Overcash, at Membership@isth.org and + 1 919 929 3807.

In Memoriam

  1. Top of page
  2. In Memoriam
  3. Pier M Mannucci Awards
  4. ISTH Visiting Professor Program
  5. ISTH Advanced Fellowships for young colleagues from underprivileged countries
  6. Novo Nordisk Haemophilia Foundation (NNHF) website (http://www.nnhf.org) is activated
  7. 5th Congress of the European Association for Haemophilia and Allied Disorders (EAHAD)
  8. 2nd Maastricht School on Thrombin Generation

We are much saddened by the news of the death on 26 November 2011, of the prominent hematologist Dr José Martín Villar. Dr. Martín Villar graduated from the Valencia Medical School and underwent training in Internal Medicine in Ottawa, under the direction of Dr Smily, remaining in Canada for eleven years. He completed his training in the Transfusion Medical Center, Leeds, UK.

After finishing his training he returned to Madrid in 1965. This period was characterized by the transformation and modernization of medicine in Spain to which Dr. Martin Villar made important contributions. He became the Chief of Hematology and Hemotherapy of La Paz University Hospital, in Madrid, and made his hematology service a reference center for the entire country.

Prominent amongst his many accomplishments was the modernization and transformation of hemotherapy in Spain, an area that had been neglected since the Spanish civil war. He created the Hemophilia Unit, for the diagnosis of and management of bleeding disorders, including the use of plasma components, and surgery as well as education and training in allaspects of hemophilia. The department became a model for the establishment of other regional centers in Spain, and he gave the center national and international recognition by establishing the Spanish Hemophilia Association and its relationship to the World Hemophilia Federation. Years later Dr. Martín Villar developed the Royal Foundation “Reina Victoria”, aimed at improving the wellbeing of hemophilic patients. A further major accomplishment was his role in establishing the specialty of Hematology and Hemotherapy as an integrated unit in Spanish hospitals.

Dr. Martín Villar formed many connections and also friendships with his international colleagues and participated in numerous international meetings, activities which allowed him to introduce the most recent approaches for the management of hemophilic patients.

José Martín Villar (Pepe as he was called by his friends) had a warm personality, and was very accessible, and he will be sorely missed by his friends and colleagues. He remained very lucid to the end of his life, died at the age of 89, and was deeply affected by the recent death of his wife Lorna. He is survived by two sons and five grand-children.

Dr José Luis Navarro

inline image

Pier M Mannucci Awards

  1. Top of page
  2. In Memoriam
  3. Pier M Mannucci Awards
  4. ISTH Visiting Professor Program
  5. ISTH Advanced Fellowships for young colleagues from underprivileged countries
  6. Novo Nordisk Haemophilia Foundation (NNHF) website (http://www.nnhf.org) is activated
  7. 5th Congress of the European Association for Haemophilia and Allied Disorders (EAHAD)
  8. 2nd Maastricht School on Thrombin Generation

Prizes will be awarded to young investigators who publish articles in the Journal of Thrombosis and Haemostasis in 2012.

The awards have been named in honour of Prof. P.M. Mannucci, the first Editor in Chief of JTH, and are made possible by a generous contribution from Bayer HealthCare. Recipients are selected by a jury of editors. Proof of age is required. Please contact editorialofficejth@imperial.ac.uk for more information.

ISTH Visiting Professor Program

  1. Top of page
  2. In Memoriam
  3. Pier M Mannucci Awards
  4. ISTH Visiting Professor Program
  5. ISTH Advanced Fellowships for young colleagues from underprivileged countries
  6. Novo Nordisk Haemophilia Foundation (NNHF) website (http://www.nnhf.org) is activated
  7. 5th Congress of the European Association for Haemophilia and Allied Disorders (EAHAD)
  8. 2nd Maastricht School on Thrombin Generation

ISTH announces a new program targeted to Thrombosis and Hemostasis Centers in underprivileged countries. The program provides for an expert visiting professor who will offer an intensive course on a selected issue, or a series of lectures on selected topics, as agreed with the host center. The duration of the visit is four to seven days, and ISTH covers airfare, accommodation and living expenses for the Visiting Professor.

Applications and details are available from the ISTH homepage, http://www.isth.org, at the Program Announcement. For more information, contact ISTH headquarters by email (headquarters@isth.org).

ISTH Advanced Fellowships for young colleagues from underprivileged countries

  1. Top of page
  2. In Memoriam
  3. Pier M Mannucci Awards
  4. ISTH Visiting Professor Program
  5. ISTH Advanced Fellowships for young colleagues from underprivileged countries
  6. Novo Nordisk Haemophilia Foundation (NNHF) website (http://www.nnhf.org) is activated
  7. 5th Congress of the European Association for Haemophilia and Allied Disorders (EAHAD)
  8. 2nd Maastricht School on Thrombin Generation

ISTH announces a new program targeted to advanced Fellows from underprivileged countries who wish to pursue knowledge and expertise in one or all of the following areas: medical care, laboratory methods, or research related to thrombosis and hemostasis. Applicants should be 37 years old or younger. Fellowships will be up to a four month period, and will include economy class travel and housing. Applications will be approved on a competitive basis by the ISTH Educational committee.

Deadlines for submission of applications are 1 January and 1 June of each year, and can be found on the ISTH homepage, http://www.isth.org, at the Fellowship Announcement. For more information, contact ISTH headquarters by email (headquarters@isth.org).

Novo Nordisk Haemophilia Foundation (NNHF) website (http://www.nnhf.org) is activated

  1. Top of page
  2. In Memoriam
  3. Pier M Mannucci Awards
  4. ISTH Visiting Professor Program
  5. ISTH Advanced Fellowships for young colleagues from underprivileged countries
  6. Novo Nordisk Haemophilia Foundation (NNHF) website (http://www.nnhf.org) is activated
  7. 5th Congress of the European Association for Haemophilia and Allied Disorders (EAHAD)
  8. 2nd Maastricht School on Thrombin Generation

NNHF was created in 2005 as an independent, non-commercial organisation in Zurich, Switzerland, to address the significant need for improving haemophilia care and treatment in the developing world. NNHF works with partners in governments, NGOs and healthcare specialists in supporting development programmes, such as the education and training of patients, doctors, nurses and laboratory technicians, the improvement of disease diagnosis and the establishment of patient registries. NNHF also offers awards and fellowships. Contact at http://info@nnhf.org.

5th Congress of the European Association for Haemophilia and Allied Disorders (EAHAD)

  1. Top of page
  2. In Memoriam
  3. Pier M Mannucci Awards
  4. ISTH Visiting Professor Program
  5. ISTH Advanced Fellowships for young colleagues from underprivileged countries
  6. Novo Nordisk Haemophilia Foundation (NNHF) website (http://www.nnhf.org) is activated
  7. 5th Congress of the European Association for Haemophilia and Allied Disorders (EAHAD)
  8. 2nd Maastricht School on Thrombin Generation

22–24 February 2012, in Rome, Italy. The 5th edition of the annual EAHAD Congress will be organized by P.M. Mannucci in the cosmopolitan atmosphere of Rome. It will deal with topics regarding clinical care, education and research on haemophilia and other bleeding disorders.

Submit your abstracts on-line from 1 September (deadline for abstract submission: 30 November). For information, online registration and abstract submission, please visit: http://www.eahad2012.org.

2nd Maastricht School on Thrombin Generation

  1. Top of page
  2. In Memoriam
  3. Pier M Mannucci Awards
  4. ISTH Visiting Professor Program
  5. ISTH Advanced Fellowships for young colleagues from underprivileged countries
  6. Novo Nordisk Haemophilia Foundation (NNHF) website (http://www.nnhf.org) is activated
  7. 5th Congress of the European Association for Haemophilia and Allied Disorders (EAHAD)
  8. 2nd Maastricht School on Thrombin Generation

2–5 October, 2012, in Maastricht, the Netherlands. For the second time Maastricht will be the stage for the Maastricht School on Thrombin Generation. The meeting will be 4–day event held at the Cardiovascular Research Institute Maastricht (CARIM), Maastricht. The activities will comprise:

1) Lectures by experienced faculty

2) Hands on experience with different available techniques

3) Master-classes in which attendees have the opportunity to present their proper research before a panel from the faculty.

The number of attendees is restricted to 100 and the registration fee shall include lodging and meals. Candidates are invited to send an abstract of no more than 300 words on the work that they wish to present. The best three abstracts will be granted an award equal to the registration fee. Five stipends are available for young scientists from developing countries or severely financially restricted. Admittance is on quality of abstract. Registration deadline is 1 June 2012.

For more information please contact Dr Raed Al Dieri (r.aldieri@thrombin.com) or Dr Bas de Laat (b.delaat@thrombin.com).